Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading LXRX News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.76% | 172.50 | 1.1% | $711.75m | |
| GILD | Gilead Sciences, Inc. | 0.09% | 70.54 | 0.9% | $695.99m | |
| CELG | Celgene Corporation | 0.47% | 134.31 | 1.1% | $649.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.75% | 517.33 | 2.7% | $572.31m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.13% | 126.07 | 1.9% | $521.18m | |
| BIIB | Biogen Inc. | -0.09% | 280.32 | 1.2% | $500.23m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.50% | 133.50 | 1.9% | $279.31m | |
| INCY | Incyte Corporation | 0.48% | 136.28 | 2.6% | $278.87m | |
| CLVS | Clovis Oncology, Inc. | -1.84% | 95.00 | 18.0% | $249.90m | |
| TSRO | TESARO, Inc. | -2.16% | 146.53 | 14.7% | $249.01m | |
| ILMN | Illumina, Inc. | 1.25% | 185.28 | 3.5% | $164.61m | |
| BLUE | Bluebird Bio, Inc. | -5.49% | 112.00 | 19.3% | $162.00m | |
| PBYI | Puma Biotechnology, Inc. | 1.22% | 87.50 | 21.1% | $145.68m | |
| KITE | Kite Pharma, Inc. | 7.09% | 100.66 | 16.1% | $139.56m | |
| EXAS | Exact Sciences Corporation | 2.31% | 35.51 | 26.3% | $130.55m |
Company Profile
Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.,05NG9Y-E